Market Closed -
Nasdaq
16:30:00 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
6.12
USD
|
+1.32%
|
|
+9.68%
|
+2.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46.93
|
70.91
|
41.18
|
18.27
|
35.73
|
36.26
|
-
|
-
|
Enterprise Value (EV)
1 |
46.93
|
70.91
|
41.18
|
18.27
|
35.73
|
36.26
|
36.26
|
36.26
|
P/E ratio
|
-1.03
x
|
-2.6
x
|
-2.01
x
|
-0.82
x
|
-1.74
x
|
-3.39
x
|
-6.09
x
|
55.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
19.6
x
|
20.3
x
|
7.55
x
|
2.13
x
|
2.23
x
|
1.51
x
|
1.04
x
|
0.73
x
|
EV / Revenue
|
19.6
x
|
20.3
x
|
7.55
x
|
2.13
x
|
2.23
x
|
1.51
x
|
1.04
x
|
0.73
x
|
EV / EBITDA
|
-1.2
x
|
-
|
-2.09
x
|
-0.82
x
|
-1.95
x
|
-2.34
x
|
-3.54
x
|
-
|
EV / FCF
|
-1.04
x
|
-
|
-
|
-1.1
x
|
-2.4
x
|
-4.31
x
|
-13.4
x
|
4.91
x
|
FCF Yield
|
-96.2%
|
-
|
-
|
-91.1%
|
-41.6%
|
-23.2%
|
-7.46%
|
20.4%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,968
|
3,030
|
4,713
|
4,745
|
6,002
|
6,003
|
-
|
-
|
Reference price
2 |
23.85
|
23.40
|
8.737
|
3.851
|
5.952
|
6.120
|
6.120
|
6.120
|
Announcement Date
|
20-03-23
|
21-03-11
|
22-03-10
|
23-03-08
|
24-03-13
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2.39
|
3.496
|
5.451
|
8.592
|
16.03
|
23.94
|
34.71
|
49.84
|
EBITDA
1 |
-38.98
|
-
|
-19.66
|
-22.33
|
-18.31
|
-15.5
|
-10.24
|
-
|
EBIT
1 |
-46.09
|
-24.75
|
-20.04
|
-22.87
|
-19.27
|
-12.75
|
-6.613
|
1.176
|
Operating Margin
|
-1,928.41%
|
-707.95%
|
-367.68%
|
-266.22%
|
-120.21%
|
-53.25%
|
-19.05%
|
2.36%
|
Earnings before Tax (EBT)
1 |
-45.13
|
-24.68
|
-18.07
|
-22.59
|
-19.02
|
-13.3
|
-7.396
|
-
|
Net income
1 |
-45.15
|
-23.51
|
-17.22
|
-22.16
|
-18.83
|
-12.62
|
-7.396
|
-
|
Net margin
|
-1,889.04%
|
-672.55%
|
-315.86%
|
-257.94%
|
-117.49%
|
-52.7%
|
-21.31%
|
-
|
EPS
2 |
-23.10
|
-9.000
|
-4.350
|
-4.690
|
-3.420
|
-1.806
|
-1.005
|
0.1100
|
Free Cash Flow
1 |
-45.14
|
-
|
-
|
-16.64
|
-14.87
|
-8.415
|
-2.706
|
7.386
|
FCF margin
|
-1,888.54%
|
-
|
-
|
-193.73%
|
-92.79%
|
-35.15%
|
-7.8%
|
14.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-23
|
21-03-11
|
22-03-10
|
23-03-08
|
24-03-13
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
1.487
|
1.491
|
1.899
|
2.157
|
1.976
|
2.56
|
2.78
|
3.551
|
4.508
|
5.191
|
4.786
|
5.485
|
6.41
|
7.256
|
7.88
|
EBITDA
1 |
-0.7632
|
-5.377
|
-5.475
|
-5.679
|
-5.403
|
-5.769
|
-6.075
|
-4.458
|
-3.835
|
-3.731
|
-4.557
|
-4.153
|
-3.179
|
-3.196
|
-
|
EBIT
1 |
-3.985
|
-5.472
|
-5.581
|
-5.82
|
-5.556
|
-5.917
|
-6.197
|
-4.988
|
-4.126
|
-3.958
|
-3.958
|
-3.468
|
-2.856
|
-2.385
|
-2.59
|
Operating Margin
|
-267.97%
|
-367.04%
|
-293.89%
|
-269.82%
|
-281.17%
|
-231.13%
|
-222.91%
|
-140.47%
|
-91.53%
|
-76.25%
|
-82.7%
|
-63.22%
|
-44.56%
|
-32.86%
|
-32.87%
|
Earnings before Tax (EBT)
1 |
-3.985
|
-4.921
|
-5.582
|
-5.782
|
-5.453
|
-5.776
|
-6.078
|
-4.903
|
-4.032
|
-4.007
|
-4.104
|
-3.644
|
-2.957
|
-2.491
|
-2.62
|
Net income
1 |
-3.994
|
-4.947
|
-5.582
|
-5.337
|
-5.453
|
-5.79
|
-5.867
|
-4.903
|
-4.032
|
-4.032
|
-3.931
|
-3.435
|
-2.821
|
-2.348
|
-2.62
|
Net margin
|
-268.56%
|
-331.82%
|
-293.94%
|
-247.43%
|
-275.96%
|
-226.17%
|
-211.04%
|
-138.07%
|
-89.44%
|
-77.67%
|
-82.13%
|
-62.63%
|
-44%
|
-32.36%
|
-33.25%
|
EPS
2 |
-0.9000
|
-1.050
|
-1.200
|
-1.200
|
-1.200
|
-1.220
|
-1.240
|
-1.030
|
-0.6800
|
-0.6100
|
-0.5880
|
-0.5040
|
-0.4040
|
-0.3140
|
-0.3400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-04
|
22-03-10
|
22-05-05
|
22-08-04
|
22-11-03
|
23-03-08
|
23-05-03
|
23-08-09
|
23-11-08
|
24-03-13
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-45.1
|
-
|
-
|
-16.6
|
-14.9
|
-8.42
|
-2.71
|
7.39
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.07
|
-
|
-
|
-
|
0.21
|
0.2
|
0.3
|
-
|
Capex / Sales
|
2.92%
|
-
|
-
|
-
|
1.29%
|
0.84%
|
0.86%
|
-
|
Announcement Date
|
20-03-23
|
21-03-11
|
22-03-10
|
23-03-08
|
24-03-13
|
-
|
-
|
-
|
Last Close Price
6.04
USD Average target price
23.1
USD Spread / Average Target +282.45% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.82% | 36.26M | | +73.17% | 12.37B | | -18.08% | 7.96B | | +16.24% | 7.09B | | +3.39% | 5.83B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4B | | -35.34% | 2.41B | | +2.10% | 2B |
Medical Equipment
|